By Alison Moore2010-07-01T12:00:00
Some see the abolition of central performance management of the 18 weeks referral to treatment target as a big mistake, others think it heralds a more flexible system. Alison Moore looks at the early outlook for a controversial change of policy
With a HSJ subscription you’ll unlock:
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud